申请人:Inthera Bioscience AG
公开号:US10710975B2
公开(公告)日:2020-07-14
The present invention relates to novel compounds of formula (I) or formula (Ia)
pharmaceutically-acceptable salts, hydrates, solvates, or stereoisomers thereof, and pharmaceutical compositions of these compounds which are useful for preventive and therapeutic use in human and veterinary medicine.
本发明涉及式 (I) 或式 (Ia) 的新型化合物
其药学上可接受的盐、水合物、溶液或立体异构体,以及这些化合物的药物组合物,可用于人类和兽医的预防和治疗。